Untreated PKU Patients without Intellectual Disability: What Do They Teach Us?

Area of Science:

• Biochemistry
• Neuroscience
• Genetics

Background:

• Phenylketonuria (PKU) management focuses on controlling plasma phenylalanine levels to prevent neurocognitive and psychosocial dysfunction.
• Individual responses to phenylalanine concentrations vary, questioning universal treatment targets.
• Understanding inter-individual differences in brain vulnerability is crucial for optimizing PKU patient outcomes.

Purpose of the Study:

• To identify and characterize untreated/late-diagnosed PKU patients with near-normal outcomes despite high phenylalanine levels.
• To investigate the neurological, psychological, and behavioral profiles of these "unusual" PKU cases.
• To explore potential differences in PKU pathophysiology and brain vulnerability mechanisms.

Main Methods:

• Case identification of 16 untreated or late-diagnosed PKU patients with high phenylalanine levels and near-normal outcomes.
• Assessment of intellectual functioning, neurological, psychological, and behavioral status in identified cases.
• Analysis of case data to challenge classical PKU symptomatology and explore underlying mechanisms.

Main Results:

• Identified 16 PKU cases with high phenylalanine levels but relatively unaffected intellectual functioning.
• Observed neurological, psychological, and behavioral problems in these patients, indicating broader PKU effects.
• Demonstrated that lack of intellectual dysfunction does not equate to absence of phenylalanine toxicity.

Conclusions:

• Classical PKU symptomatology may need revision based on these atypical cases.
• High phenylalanine levels can be toxic to the brain even without overt intellectual impairment.
• PKU pathophysiology likely involves multiple, variable mechanisms influencing brain effects differently across individuals and ages.